AHCO — Adapthealth Cashflow Statement
0.000.00%
Last trade - 00:00- $1.13bn
- $3.05bn
- $3.26bn
- 84
- 97
- 65
- 96
Annual cashflow statement for Adapthealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -58.7 | 158 | 73.1 | -675 | 94.8 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 116 | -9.6 | 39.5 | 860 | 75.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 76.9 | -153 | -108 | -25.1 | -26.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 196 | 276 | 374 | 481 | 542 |
| Capital Expenditures | -39.8 | -203 | -391 | -337 | -306 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -776 | -1,621 | -19.7 | -19.8 | -4.22 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -816 | -1,825 | -411 | -357 | -310 |
| Financing Cash Flow Items | -104 | -71.9 | -18.4 | -12.1 | -19.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 643 | 1,599 | -66.1 | -92.5 | -199 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.1 | 49.7 | -103 | 30.9 | 32.6 |